Clinical Oncology Society of Australia Annual Scientific Meeting 2020
Tuesday, 10th November
Wednesday, 11th November
Thursday, 12th November
Friday, 13th November
Saturday, 14th November
Abstracts this author is presenting:
Addition of netupitant to 5HT3-receptor antagonist/dexamethasone prophylaxis with FOLFOX reduces rates of chemotherapy-induced nausea and vomiting (CINV).